2m 2m 2m 2m 2m 2m 2m
Ionis Pharmaceut (IONS)
NASDAQ
$54.85+$0.64 (+1.18%)
Price as of Sep 11, 2026 7:52 PM EDT- $9.0BMarket Cap
- -14.17%1-Year Change
- BiotechnologyIndustry
Ionis Pharmaceut (IONS)
$54.85+$0.64 (+1.18%)
IONS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $54.21 | ||
Change | -$1.44 (-2.59%) | ||
Open | $55.94 | ||
High | $56.16 | ||
Low | $54.16 | ||
Previous Close | $55.65 | ||
Volume | 2,183,677 | ||
30-Day Average Volume | 2,647,493 | ||
1-Week Change | -6.68% | ||
1-Month Change | -2.18% | ||
1-Year Change | -14.17% | ||
3-Year Change | 31.29% | ||
5-Year Change | 50.21% | ||
Fundamentals | |||
Shares Outstanding | 166.2M | ||
Total Assets | $3.0B | ||
Market Cap | $9.0B | ||
Enterprise Value | $9.4B | ||
Period: QTR TTM FY | |||
Revenue | $31.1M | ||
Net Income | -$114.6M | ||
Free Cash Flow | $549.5M | ||
EBIT | -$108.8M | ||
EBITDA | -$108.1M | ||
Net Working Capital | $2.2B | ||
EPS | -$0.69 | ||
Enterprise Value/EBITDA | -87 | ||
Enterprise Value/Revenue | 302 | ||
P/B | 20 | ||
P/E | -79 | ||
PEG | 3 | ||
Price/Free Cash Flow | 16 | ||
Price/Operating Cash Flow | 16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue